PuriCore Investment Thesis
- There is a critical need for safe, effective, natural solutions to control the spread of infectious pathogens.
- Our technology is scientifically proven and intellectually protected.
- We already have significant share and leadership in our core markets.
- We have a proven business model with strong year-on-year revenue and margin growth.
Latest Announcements
Information on this page is updated via a feed from the London Stock Exchange's Regulatory News Service.
- 24/02/10 - PuriCore Plc - Blocklisting Interim Review
- 20/01/10 - PuriCore Plc - Trading Statement
- 12/11/09 - PuriCore Plc - Change of Adviser
15 minute delayed prices from the London Stock Exchange provided by Hemscott Group Limited.
